These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36370835)

  • 1. Locally Advanced Cutaneous Squamous Cell Carcinoma Treated With Immunotherapy in a Dermatology Department.
    Navarro Navarro I; Villegas Romero I; Jiménez Gallo D; Linares Barrios M
    Actas Dermosifiliogr; 2023 Mar; 114(3):285-287. PubMed ID: 36370835
    [No Abstract]   [Full Text] [Related]  

  • 2. Cemiplimab-rwlc in advanced cutaneous squamous cell carcinoma: real-world experience in a French dermatology department.
    Guillaume T; Puzenat E; Popescu D; Aubin F; Nardin C
    Br J Dermatol; 2021 Nov; 185(5):1056-1058. PubMed ID: 34107076
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dermatology - Update on systemic treatments for locally advanced and/or metastatic cutaneous squamous cell carcinoma].
    Brocco E
    Rev Med Suisse; 2023 Feb; 19(812):207-211. PubMed ID: 36723649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cemiplimab in cutaneous squamous cell carcinomas (SCC): an overview and a clinical case.
    Ghidini A; Santangelo D; Vaccaro G; Chillura M; Petrelli F
    Oral Oncol; 2022 May; 128():105847. PubMed ID: 35367788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multimodality Therapy for Locally Advanced Cutaneous Squamous Cell Carcinoma].
    Garzarolli M; Bota O; Meinhardt M; Juratli T; Meier F
    Laryngorhinootologie; 2023 Aug; 102(8):612-615. PubMed ID: 36395785
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of unresectable cutaneous squamous cell carcinoma with pembrolizumab.
    Venkatesh S; Al-Haseni A; Sahni D
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31377718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
    Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
    Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant cemiplimab induces durable complete response in locally advanced cutaneous squamous cell carcinoma.
    Geidel G; Adam L; Rünger A; Menz A; Kött J; Haalck T; Gebhardt C
    J Eur Acad Dermatol Venereol; 2023 Dec; 37(12):e1414-e1416. PubMed ID: 37458533
    [No Abstract]   [Full Text] [Related]  

  • 9. Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.
    Migden MR; Khushalani NI; Chang ALS; Lewis KD; Schmults CD; Hernandez-Aya L; Meier F; Schadendorf D; Guminski A; Hauschild A; Wong DJ; Daniels GA; Berking C; Jankovic V; Stankevich E; Booth J; Li S; Weinreich DM; Yancopoulos GD; Lowy I; Fury MG; Rischin D
    Lancet Oncol; 2020 Feb; 21(2):294-305. PubMed ID: 31952975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience in a Monographic Oncology Center.
    Ríos-Viñuela E; Álvarez P; Lavernia J; Serra-Guillén C; Requena C; Bernia E; Diago A; Llombart B; Sanmartín O
    Actas Dermosifiliogr; 2022 Jun; 113(6):T610-T615. PubMed ID: 35525283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience in a Monographic Oncology Center.
    Ríos-Viñuela E; Álvarez P; Lavernia J; Serra-Guillén C; Requena C; Bernia E; Diago A; Llombart B; Sanmartín O
    Actas Dermosifiliogr; 2022 Jun; 113(6):610-615. PubMed ID: 35431057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination regimens and immunologic mechanisms to enhance the efficacy of cemiplimab for cutaneous squamous cell carcinoma.
    Hanania HL; Lewis DJ
    Expert Rev Anticancer Ther; 2022 Feb; 22(2):237-238. PubMed ID: 34918605
    [No Abstract]   [Full Text] [Related]  

  • 13. [Locally advanced and metastatic cutaneous squamous cell carcinoma treated with cemiplimab].
    Vanhakendover L; Lebas E; Libon F; Wauters O; Dezfoulian B; Marchal N; Rorive A; Piret P; Quatresooz P; Jacquemin D; Nikkels AF
    Rev Med Liege; 2019 Jul; 74(7-8):436-440. PubMed ID: 31373461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pembrolizumab as monotherapy in locally advanced cutaneous squamous cell carcinoma.
    Giri A; Bauman JR
    Expert Rev Anticancer Ther; 2022 Oct; 22(10):1029-1038. PubMed ID: 36106496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma.
    Villani A; Ocampo-Garza SS; Potestio L; Fabbrocini G; Ocampo-Candiani J; Ocampo-Garza J; Scalvenzi M
    Expert Opin Drug Saf; 2022 Jan; 21(1):21-29. PubMed ID: 34644510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of cemiplimab for advanced cutaneous squamous cell carcinoma in a patient with p-ANCA-associated vasculitis.
    Pham JP; Sivasubramaniam V; Gallagher R; Forstner D; Wong M; Liu J
    J Eur Acad Dermatol Venereol; 2023 Mar; 37(3):e363-e365. PubMed ID: 36226470
    [No Abstract]   [Full Text] [Related]  

  • 17. RF-Cemiplimab: First Drug Approved for the Treatment of Metastatic or Unresectable Cutaneous Squamous Cell Carcinoma.
    Morgado-Carrasco D; Bosch-Amate X; Fustà-Novell X; Giavedoni P
    Actas Dermosifiliogr (Engl Ed); 2020 Mar; 111(2):161-163. PubMed ID: 31874704
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple keratin granulomata: A potential histologic clue to cutaneous squamous cell carcinoma responding to programmed cell death protein 1 inhibitor therapy.
    Kahn BJ; Parker D; Yushak M; Stoff B; Blalock TW
    J Cutan Pathol; 2019 Jun; 46(6):452-454. PubMed ID: 30811629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Programmed Cell Death Ligand in Cutaneous Squamous Cell Carcinoma and Treatment of Locally Advanced Disease With Pembrolizumab.
    Stevenson ML; Wang CQ; Abikhair M; Roudiani N; Felsen D; Krueger JG; Pavlick AC; Carucci JA
    JAMA Dermatol; 2017 Apr; 153(4):299-303. PubMed ID: 28259107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Validity of the current classification of cutaneous squamous cell carcinoma].
    Meier K; Yazdi AS
    Hautarzt; 2013 May; 64(5):384-6. PubMed ID: 23595892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.